MDC1 and cancer: One is the PARP1-MYC pathway for BIN1 reduction, which spontaneously emerges when cancer cells become cisplatin-resistant, and the other is the ATM-phosphorylated MDC1-RNF8 signaling pathway by a BIN1 loss.